Earnings Call · Q4 FY2022·2023-03-06

Q4 22EPS +90.00%·Rev n/aQ3 22EPS +8.33%·Rev n/aQ2 22EPS -20.00%·Rev n/aQ1 22EPS -100.00%*·Rev n/a⚠ consensus missing

Orthofix Medical Inc. OFIX

Alexa Huerta — Senior Director of Investor Relations

Keith Valentine — President and Chief Executive Officer

John Bostjancic — Chief Financial Officer

Jon Serbousek — Unknown - likely senior executive involved in financial reporting or investor relations

Doug Rice — Unknown - likely senior finance or investor relations based on context

−6.6%1d on move date−6.5% vs SPY3d−6.6%5d−4.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more OFIX calls or request research access.

More OFIX calls Browse calls Request research access